REGN - Regeneron Pharmaceuticals
Annual data, 1996 to 2026, in US$ millions.
Last updated: Oct 3, 2026
Capital
Dividend
Revenue
Income
Asset
Equity
Rolling CAGR% per year, window ending each year
Other companies
Moderna
Data since 2016
WuXi AppTec
Data since 2014
GSK plc
Data since 1996
Sanofi
Data since 2001
Bristol-Myers Squibb
Data since 1996
Vertex Pharmaceuticals
Data since 1996
Pfizer
Data since 1996
Novo Nordisk
Data since 1996
Gilead Sciences
Data since 1996

Amgen
Data since 1996

AstraZeneca
Data since 1996

Novartis
Data since 1998

Roche
Data since 1998

Merck
Data since 1996

AbbVie
Data since 2010

Johnson & Johnson
Data since 1996

Eli Lilly
Data since 1996
CVS Health
Data since 1996

Thermo Fisher Scientific
Data since 1996
CITIC Bank
Data since 2003
American Tower
Data since 1997
CPKC (Canadian Pacific Kansas City)
Data since 1997
EOG Resources
Data since 1996
The Travelers Companies
Data since 1996
Intuit
Data since 1996
Simon Property Group
Data since 1996
NetEase
Data since 2000
Moody's
Data since 1998
Illinois Tool Works
Data since 1996
National Grid
Data since 2001
2026 is partial: Capital is the current value; Revenue and Income are TTM; Asset and Equity are the latest quarter reported. CAGR runs through 2026. Rolling CAGR needs positive values at both ends of the window. Dividend = yield × Capital (approximate). Orange bars mark years that fell from the prior year. Y axes are log scale, so zero or negative values are not shown. Relative mode divides each series by its first positive value (capped at 500x, 1000x or 3000x, depending on the button); Absolute shows real values.